Hilde Kooistra

Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists

Hilde Kooistra, Agneta Calf, Margriet Piersma‐Wichers et al. · JAMA Internal Medicine · 2016 · 50 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Renée Bouwstra, Yuan He, Janneke de Boer et al. · Cancer Immunology Research · 2019 · 41 citations · Full text

Medicine, Immunology, Oncology +17

Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients

Nic J.G.M. Veeger, Nakisa Khorsand, Hanneke C. Kluin‐Nelemans et al. · Thrombosis and Haemostasis · 2014 · 14 citations

Medicine, Pharmacology, Pharmacotherapy +17

Impact of Vitamin K Antagonists on Quality of Life in a Prospective Cohort of 807 Atrial Fibrillation Patients

Hilde Kooistra, Margriet Piersma‐Wichers, Hanneke C. Kluin‐Nelemans et al. · Circulation Cardiovascular Quality and Outcomes · 2016 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Quality of life after switching from well-controlled vitamin K antagonist to direct oral anticoagulant: Little to GAInN

Jasper H.A. van Miert, Hilde Kooistra, Nic J.G.M. Veeger et al. · Thrombosis Research · 2020 · 11 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17